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Background:  Aspirin (ASA) has been shown to reduce postoperative CABG mortality and ischemic events. There are no data on the time of ASA 
discontinuation and its effect on CABG with valve surgery and bleeding complications.
Methods and Results: Between January 1, 2002, and January 31, 2008, 1963 patients undergoing non-urgent CABG plus valve surgery at CCF 
were on preoperative ASA. 1404 (72%) discontinued ASA greater than 5 days prior to surgery (early discontinuation) and 559 (28%) continued ASA 
within 5 days of surgery (late use). Propensity score analysis and matching were employed for fair comparison of outcomes. There was no difference 
with regards to the composite outcome of in-hospital mortality, myocardial infarction (MI), and stroke (5.3 % in both groups). There was similar use 
of intraoperative red blood cell (RBC) transfusions, 45% in the early discontinuation vs. 43% in the late use group (p=0.4). More patients in the late 
use group received postoperative transfusions (49% vs. 42%, p=0.02). There was a trend toward increased reoperation for bleeding (31 (6.1%) vs. 
19 (3.7%), p = 0.08) in the late use group.
Conclusions: Among patients undergoing CABG with valve surgery, there was no difference in outcomes with regards to timing of ASA 
discontinuation except for increased use of postoperative RBC transfusion and a trend toward increased reoperation for bleeding in the late ASA 
group. Late preoperative use of ASA in CABG with valve surgery must be weighed against increased risk of bleeding. 
